Interestingly, our enrichment analysis found that the identified differential expression of the genes (AKT1, VEGFA, CDK6, and MAPK9) that were involved in the risk of developing pancreatic cancer in SLE patients was due to chronic inflammation, suggesting that these genes might be involved in the pathogenesis of SLE. Here, MAPK9 is linked to familial pancreatic carcinoma.